Literature DB >> 18799590

Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions.

Stacey A Leisenfelder1, Paul R Kinchington, Jennifer F Moffat.   

Abstract

Varicella-zoster virus (VZV), an alphaherpesvirus restricted to humans, infects differentiated cells in vivo, including T lymphocytes, keratinocytes, and neurons, and spreads rapidly in confluent cultured dermal fibroblasts (HFFs). In VZV-infected HFFs, atypical expression of cyclins D3 and B1 occurs along with the induction of cyclin-dependent kinase (CDK) activity. A specific CDK1 inhibitor blocked VZV spread, indicating an important function for this cellular kinase in VZV replication. CDK activity assays of infected cells revealed a large viral phosphoprotein that was identified as being the major immediate-early transactivator, IE62. Since IE62 colocalized with CDK1/cyclin B1 by confocal microscopy, we investigated whether this cellular kinase complex interacts with IE62. Using recombinant fragments of IE62 spanning the entire amino acid sequence, we found that purified CDK1/cyclin B1 phosphorylated IE62 at residues T10, S245, and T680 in vitro. Immunoprecipitation of cyclin B1 from VZV-infected HFFs indicated that IE62 was included in the complex within infected cells. The full-length IE62 protein, obtained by immunoprecipitation from infected cells, was also phosphorylated by purified CDK1/cyclin B1. Based on IE62/CDK1/cyclin B1 colocalization near viral assembly regions, we hypothesized that these cellular proteins could be incorporated into VZV virions with IE62. Purified virions were analyzed by immunoblotting for the presence of CDK1 and cyclin B1, and active CDK1 and cyclin B1 were present in the VZV tegument with IE62 and were sensitive to detergent treatment. Thus, IE62 is a substrate for CDK1/cyclin B1, and virions could deliver the active cellular kinase to nondividing cells that normally do not express it.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799590      PMCID: PMC2593305          DOI: 10.1128/JVI.00153-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.

Authors:  Jill T Bechtel; Richard C Winant; Don Ganem
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Phosphorylation of varicella-zoster virus glycoprotein gpI by mammalian casein kinase II and casein kinase I.

Authors:  C Grose; W Jackson; J A Traugh
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Role for Cdk1 (Cdc2)/cyclin A in preventing the mammalian origin recognition complex's largest subunit (Orc1) from binding to chromatin during mitosis.

Authors:  Cong-jun Li; Alex Vassilev; Melvin L DePamphilis
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

4.  Interaction between the varicella zoster virus IE62 major transactivator and cellular transcription factor Sp1.

Authors:  Hua Peng; Hongying He; John Hay; William T Ruyechan
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

5.  Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8.

Authors:  Travis J Taylor; David M Knipe
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Substrate specificity of CDK2-cyclin A. What is optimal?

Authors:  Lisa M Stevenson-Lindert; Paul Fowler; John Lew
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

7.  Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.

Authors:  Shannon L Taylor; Paul R Kinchington; Andrew Brooks; Jennifer F Moffat
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 8.  Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis.

Authors:  Jennifer F Moffat; Michelle A McMichael; Stacey A Leisenfelder; Shannon L Taylor
Journal:  Biochim Biophys Acta       Date:  2004-03-11

9.  The interaction of ICP4 with cell/infected-cell factors and its state of phosphorylation modulate differential recognition of leader sequences in herpes simplex virus DNA.

Authors:  A G Papavassiliou; K W Wilcox; S J Silverstein
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

10.  Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins.

Authors:  Francesca Diella; Scott Cameron; Christine Gemünd; Rune Linding; Allegra Via; Bernhard Kuster; Thomas Sicheritz-Pontén; Nikolaj Blom; Toby J Gibson
Journal:  BMC Bioinformatics       Date:  2004-06-22       Impact factor: 3.169

View more
  9 in total

Review 1.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

Review 2.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

3.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

4.  Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer.

Authors:  Laura A Vella; Min Yu; Steven R Fuhrmann; Moustapha El-Amine; Diane E Epperson; Olivera J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

5.  Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.

Authors:  Jenny Rowe; Rebecca J Greenblatt; Dongmei Liu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2010-03-20       Impact factor: 5.970

6.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

7.  Functional Characterization of the Serine-Rich Tract of Varicella-Zoster Virus IE62.

Authors:  Seong K Kim; Akhalesh K Shakya; Seongman Kim; Dennis J O'Callaghan
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

8.  Regulation of the retinoblastoma proteins by the human herpesviruses.

Authors:  Adam J Hume; Robert F Kalejta
Journal:  Cell Div       Date:  2009-01-15       Impact factor: 5.130

9.  Twenty Years After Glioblastoma Multiforme Diagnosis: A Case of Long-Term Survival.

Authors:  Omar Rabab'h; Ali Al-Ramadan; Jawad Shah; Hugo Lopez-Negrete; Abeer Gharaibeh
Journal:  Cureus       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.